445 related articles for article (PubMed ID: 9988278)
21. Telomerase activity and differential expression of telomerase genes and c-myc in chicken cells in vitro.
Swanberg SE; Payne WS; Hunt HD; Dodgson JB; Delany ME
Dev Dyn; 2004 Sep; 231(1):14-21. PubMed ID: 15305283
[TBL] [Abstract][Full Text] [Related]
22. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
[TBL] [Abstract][Full Text] [Related]
23. Identification of Mad as a repressor of the human telomerase (hTERT) gene.
Oh S; Song YH; Yim J; Kim TK
Oncogene; 2000 Mar; 19(11):1485-90. PubMed ID: 10723141
[TBL] [Abstract][Full Text] [Related]
24. Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.
Biroccio A; Amodei S; Benassi B; Scarsella M; Cianciulli A; Mottolese M; Del Bufalo D; Leonetti C; Zupi G
Oncogene; 2002 May; 21(19):3011-9. PubMed ID: 12082531
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of hTERT transcription by Tax.
Gabet AS; Mortreux F; Charneau P; Riou P; Duc-Dodon M; Wu Y; Jeang KT; Wattel E
Oncogene; 2003 Jun; 22(24):3734-41. PubMed ID: 12802280
[TBL] [Abstract][Full Text] [Related]
26. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity.
Zhang PH; Zou L; Tu ZG
J Surg Res; 2006 Mar; 131(1):143-9. PubMed ID: 16298398
[TBL] [Abstract][Full Text] [Related]
27. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
28. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.
Horikawa I; Cable PL; Afshari C; Barrett JC
Cancer Res; 1999 Feb; 59(4):826-30. PubMed ID: 10029071
[TBL] [Abstract][Full Text] [Related]
29. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
30. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
31. Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor.
Bermudez Y; Yang H; Cheng JQ; Kruk PA
Growth Factors; 2008 Feb; 26(1):1-11. PubMed ID: 18365874
[TBL] [Abstract][Full Text] [Related]
32. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
[TBL] [Abstract][Full Text] [Related]
33. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.
Fujimoto K; Takahashi M
Biochem Biophys Res Commun; 1997 Dec; 241(3):775-81. PubMed ID: 9434785
[TBL] [Abstract][Full Text] [Related]
34. TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability.
Zhang P; Chan SL; Fu W; Mendoza M; Mattson MP
FASEB J; 2003 Apr; 17(6):767-9. PubMed ID: 12594176
[TBL] [Abstract][Full Text] [Related]
35. Changes in promoter utilization in human and mouse c-myc genes upon transformation induction in temperature-sensitive cell lines.
Luo Y; Krause MO
J Cell Physiol; 1994 Aug; 160(2):303-15. PubMed ID: 8040189
[TBL] [Abstract][Full Text] [Related]
36. Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.
Koh CM; Khattar E; Leow SC; Liu CY; Muller J; Ang WX; Li Y; Franzoso G; Li S; Guccione E; Tergaonkar V
J Clin Invest; 2015 May; 125(5):2109-22. PubMed ID: 25893605
[TBL] [Abstract][Full Text] [Related]
37. Constitutive overexpression of human telomerase reverse transcriptase but not c-myc blocks terminal differentiation in human HaCaT skin keratinocytes.
Cerezo A; Stark HJ; Moshir S; Boukamp P
J Invest Dermatol; 2003 Jul; 121(1):110-9. PubMed ID: 12839571
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression.
McMurray HR; McCance DJ
J Virol; 2003 Sep; 77(18):9852-61. PubMed ID: 12941894
[TBL] [Abstract][Full Text] [Related]
39. The correlation of TERT expression with c-myc expression in cervical cancer.
Sagawa Y; Nishi H; Isaka K; Fujito A; Takayama M
Cancer Lett; 2001 Jul; 168(1):45-50. PubMed ID: 11368876
[TBL] [Abstract][Full Text] [Related]
40. c-MYC and h-TERT co-expression in colon adenocarcinoma: a tissue microarray digitized image analysis.
Georgakopoulos G; Tsiambas E; Korkolopoulos P; Kavantzas N; Karameris A; Ragkos V; Rigopoulos DN; Vilaras G; Athanasiou AE; Tatsiou D; Patsouris E
J BUON; 2013; 18(1):124-30. PubMed ID: 23613397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
